Abstract
Lung cancer (LC) is a highly prevalent malignancy mainly caused by long-term exposure to tobacco smoke, although other substances in the workplace can also cause LC. This paper reviews carcinogens in the workplace linked with occupational LC, including asbestos, radon, silica, nickel, beryllium, chromium and polycyclic aromatic hydrocarbons (PAH).
In LC of occupational origin, diagnosis can be difficult due to co-exposure to various carcinogens. The present review is intended to provide additional information that may help in the diagnostic approach and discusses controversial issues on certain substances like silica, beryllium or PAH as etiological factors of LC. Finally, occupational LC preventive measures are discussed.
Keywords: Asbestos-related lung cancer, lung cancer, lung cancer risk, never-smokers, occupational lung cancer, radon-related lung cancer.
Current Respiratory Medicine Reviews
Title:Lung Cancer of Occupational Origin
Volume: 8 Issue: 6
Author(s): Ramon Fernández, Gemma Rubinos, Ana Rosa Exposito and Cristina Martinez
Affiliation:
Keywords: Asbestos-related lung cancer, lung cancer, lung cancer risk, never-smokers, occupational lung cancer, radon-related lung cancer.
Abstract: Lung cancer (LC) is a highly prevalent malignancy mainly caused by long-term exposure to tobacco smoke, although other substances in the workplace can also cause LC. This paper reviews carcinogens in the workplace linked with occupational LC, including asbestos, radon, silica, nickel, beryllium, chromium and polycyclic aromatic hydrocarbons (PAH).
In LC of occupational origin, diagnosis can be difficult due to co-exposure to various carcinogens. The present review is intended to provide additional information that may help in the diagnostic approach and discusses controversial issues on certain substances like silica, beryllium or PAH as etiological factors of LC. Finally, occupational LC preventive measures are discussed.
Export Options
About this article
Cite this article as:
Fernández Ramon, Rubinos Gemma, Rosa Exposito Ana and Martinez Cristina, Lung Cancer of Occupational Origin, Current Respiratory Medicine Reviews 2012; 8 (6) . https://dx.doi.org/10.2174/1573398X11208060003
DOI https://dx.doi.org/10.2174/1573398X11208060003 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting ABCB1 and ABCC1 with their Specific Inhibitor CBT-1<sup>®</sup> can Overcome Drug Resistance in Osteosarcoma
Current Cancer Drug Targets Characteristic Alterations of Nuclear Structure and Chromatin Organisation of Cancer Cells Addressed by Proteome Analysis**
Current Proteomics γ-H2AX as a Therapeutic Target for Improving the Efficacy of Radiation Therapy
Current Cancer Drug Targets Genomics of Addiction
Current Psychiatry Reviews Epigenetic Biomarkers for Risk Assessment of Particulate Matter Associated Lung Cancer
Current Drug Targets Single-Photon Emission Computed Tomography Tracers for Predicting and Monitoring Cancer Therapy
Current Pharmaceutical Biotechnology Marine Derived Bioactive Compounds for Breast and Prostate Cancer Treatment: A Review
Current Bioactive Compounds Advances in the Systemic Treatment of Neuroendocrine Tumors in the Era of Molecular Therapy
Anti-Cancer Agents in Medicinal Chemistry The Multidrug Resistance Mechanisms and their Interactions with the Radiopharmaceutical Probes Used for an In Vivo Detection
Current Drug Metabolism The Cyclin-Dependent Kinase Inhibitor p21CDKN1A as a Target of Anti-Cancer Drugs
Current Cancer Drug Targets Comprehensive Profiling of the Low Molecular Weight Proteins and Peptides in Weak Cation Exchange Beads Human Serum Retentate
Protein & Peptide Letters New Insights into the Treatment of Multiple Myeloma with Histone Deacetylase Inhibitors
Current Pharmaceutical Design PET Studies on P-Glycoprotein Function in the Blood-Brain Barrier: How it Affects Uptake and Binding of Drugs within the CNS
Current Pharmaceutical Design Synergistic Activity of the c-Met and Tubulin Inhibitor Tivantinib (ARQ197) with Pemetrexed in Mesothelioma Cells
Current Drug Targets PI3K/Akt/mTOR Pathway Inhibitors in Cancer: A Perspective on Clinical Progress
Current Medicinal Chemistry Preventive and Therapeutic Effects of the Retinoid X Receptor Agonist Bexarotene on Tumors
Current Drug Metabolism Targeting Metabolic Enzymes in Cancer – Clinical Trials Update
Current Enzyme Inhibition Bioactive Peptides in Preventative Healthcare: An Overview of Bioactivities and Suggested Methods to Assess Potential Applications
Current Pharmaceutical Design Marine Actinomycetes-derived Natural Products
Current Topics in Medicinal Chemistry Mesenchymal Stem Cells for Anti-Cancer Drug Delivery
Recent Patents on Anti-Cancer Drug Discovery